Pharma sector

Discussion in 'Stock Picks Of Wizards' started by Rajkumar B, Jan 7, 2017.

  1. Rajkumar B

    Rajkumar B New Member

    Joined:
    Jan 7, 2017
    Messages:
    2
    Likes Received:
    0
    In 2017 why we should not expect top pharma company to create wealth for the investors.
     
  2. mscratnesh

    mscratnesh New Member

    Joined:
    Apr 28, 2015
    Messages:
    14
    Likes Received:
    3
    due to USFDA over hang :).
     
  3. Rajkumar B

    Rajkumar B New Member

    Joined:
    Jan 7, 2017
    Messages:
    2
    Likes Received:
    0
    These hiccups will come and go.
    Should that deter people to invest in defensive and growing sector.
    Good company have always overcome these hurdles.
     
  4. mscratnesh

    mscratnesh New Member

    Joined:
    Apr 28, 2015
    Messages:
    14
    Likes Received:
    3
    agree. we need these kinds of bad time for good company to deploy our money
     
  5. RAMA MURTHY SASTRY CHALLA

    RAMA MURTHY SASTRY CHALLA Well-Known Member

    Joined:
    Sep 8, 2015
    Messages:
    3,466
    Likes Received:
    1,873
    If US new government " Fixing Prices " for non American Pharma companies , those are out side US manufacturing pharma products....
    Indian pharma industries may be effaced due to Trump policy , so wait for another few months
     
  6. adi16

    adi16 Member

    Joined:
    Dec 30, 2015
    Messages:
    52
    Likes Received:
    18
    I am invested in LPC, ARBP. Believe these will outperform as the valuations are reasonable and trading below historical averages. There may be overhang due to Trump policy, but US generic opportunity is immense and Indian companies may benefit. Also, these wo do not have any regulatory FDA issues at their plants.
     
  7. Ravikumar

    Ravikumar Active Member

    Joined:
    Nov 3, 2015
    Messages:
    137
    Likes Received:
    56
    Zoom in Cadila Healthcare today after USFDA clears.......
     
Loading...